# The Human Medicines (Amendments relating to the Windsor Framework) Regulations 2024, Regulation 47: Amendment to regulation 59

Extent: E+W+S+N.I.

In regulation 59 (conditions of UK marketing authorisation or parallel import licence: general)—
(a) in paragraph (3), for “UKMA(UK)” substitute “UKMA(UK)(Category 2)”;
(b) in paragraph (3A), after “UKMA(GB)” insert “or a UKMA(UK)(Category 1)”;
(c) in paragraph (3B)—
(i) omit “in respect of Great Britain”;
(ii) after “may be required”, insert “in relation to a UKMA(GB) or UKMA(UK)(Category 1)”;
(d) in paragraph (5), for “UKMA(UK)” substitute “UKMA(UK)(Category 2)”.

---
Source: https://www.legislation.gov.uk/uksi/2024/832/regulation/47 (the official version)
Page: https://openlegislation.uk/human-medicines-amendments-relating-to-the-windsor-framework-regulations-2024/regulation-47
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.